Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03508245 · ClinicalTrials.gov registry record · NA

Investigating Circadian Rhythms in Youth With Persistent Tic Disorders

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT03508245 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03508245, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

This study examines circadian rhythms and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD); and assesses the effects of wearable short wavelength light therapy on circadian rhythms and tic symptoms.

Interventions

  • OTHER Wearable short wavelength light therapy

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-01-18
Est. Completion 2023-06-23
Phase NA

What the Registry Record Tells You About NCT03508245

The ClinicalTrials.gov registry entry for NCT03508245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Wearable short wavelength light therapy is the first listed.

NCT03508245 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03508245 about?

NCT03508245 is a clinical study titled "Investigating Circadian Rhythms in Youth With Persistent Tic Disorders". This study examines circadian rhythms and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD); and assesses the effects of wearable short wavelength light therapy on circadian rhythms and tic symptoms.

What is the current status of trial NCT03508245?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-01-18. Estimated completion is 2023-06-23.

What interventions are being tested in trial NCT03508245?

The interventions under investigation include: Wearable short wavelength light therapy (OTHER).

Who is sponsoring clinical trial NCT03508245?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.